Clinical Research Directory

Inclusion Criteria: * Adult participants with a diagnosis of schizophrenia, as per clinical judgement * Newly prescribed or has initiated treatment with TV-44749 within the past 30 days, in accordance with the approved local label, and decided prior to and independently of participant's study participation * Availability of at least 6 months of retrospective data prior to treatment initiation * Written informed consent from the participant or an authorized representative able to provide written informed consent on behalf of the participant Exclusion Criteria: * Established diagnosis of treatment-resistant schizophrenia, including current treatment with clozapine, clozapine treatment within the past 3-months, or treatment-resistant schizophrenia in the opinion of the investigator, as documented in the medical record * Prior non-response to TV-44749 per clinician's judgement * Established current diagnosis of human immunodeficiency virus, cancers, liver failure, kidney failure, neuroleptic malignant syndrome, and diabetic ketoacidosis * The participant has any medical or psychiatric condition that, in the opinion of the investigator, could jeopardize or would compromise the participant's ability to participate in this study * Participation in a clinical trial at the time of enrollment or within previous 6 months